Evidence map›Paper›PMID 9585603›Full record

ArticleAmerican journal of human genetics1998

Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families.

I D Krantz, R P Colliton, A Genin, E B Rand, L Li, D A Piccoli, N B Spinner

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 232 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification Guidelines.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  5. Article
  6. Article
  7. A child with chronic kidney disease and hepatic dysfunction: Answers.Pediatric nephrology (Berlin, Germany) · 2023
    Article
  8. Management of adults with Alagille syndrome.Hepatology international · 2023
    Review
  9. Article
  10. Different clinical and genetic features of Alagille patients with progressive diseaseJGH open : an open access journal of gastroenterology and hepatology · 2022
    Article
  11. Multidisciplinary Management of Alagille Syndrome.Journal of multidisciplinary healthcare · 2022
    Review
  12. Long-term follow-up of a patient with JAG1-associated retinopathy.Documenta ophthalmologica. Advances in ophthalmology · 2021
    Article
  13. Observational
  14. Two Novel Mutations in theDiagnostics (Basel, Switzerland) · 2021
    Article
  15. Alagille syndrome and non-syndromic paucity of the intrahepatic bile ducts.Translational gastroenterology and hepatology · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. NovelInternational journal of molecular sciences · 2019
    Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

I D KrantzDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
R P Colliton
A Genin
E B Rand
L Li
D A Piccoli
N B Spinner
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USUniversity of Washington · US

Funding

ZIDOVUDINE VS 2',3'DIDEHYDRO-3'DEOXYTHYMIDINE IN CHILDRENM01RR000240 · NCRR · CHILDREN'S HOSP OF PHILADELPHIA · PI ALTSCHULER, STEVEN M · 1985 to 2006
$15.3M
Molecular Analysis of Alagille SyndromeR01DK053104 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI SPINNER, NANCY BETTINA · 1997 to 2006
$3.0M
GENETIC BASIS OF THE ALAGILLE SYNDROMEK08DK002338 · NIDDK · CHILDREN'S HOSPITAL OF PHILADELPHIA · PI RAND, ELIZABETH B · 1995 to 1999
–
NCRR NIH HHS 3M01RR00240-32S7CRCNIDDK NIH HHS 1R01DK53104-01NIDDK NIH HHS DK02338
6 · The paper itself

Abstract

Alagille syndrome (AGS) is a dominantly inherited disorder characterized by liver disease in combination with heart, skeletal, ocular, facial, renal, and pancreatic abnormalities. We have recently demonstrated that Jagged1 (JAG1) is the AGS gene. JAG1 encodes a ligand in the Notch intercellular signaling pathway. AGS is the first developmental disorder to be associated with this pathway and the first human disorder caused by a Notch ligand. We have screened 54 AGS probands and family members to determine the frequency of mutations in JAG1. Three patients (6%) had deletions of the entire gene. Of the remaining 51 patients, 35 (69%) had mutations within JAG1, identified by SSCP analysis. Of the 35 identified intragenic mutations, all were unique, with the exceptions of a 5-bp deletion in exon 16, seen in two unrelated patients, and a C insertion at base 1618 in exon 9, also seen in two unrelated patients. The 35 intragenic mutations included 9 nonsense mutations (26%); 2 missense mutations (6%); 11 small deletions (31%), 8 small insertions (23%), and 1 complex rearrangement (3%), all leading to frameshifts; and 4 splice-site mutations (11%). The mutations are spread across the coding sequence of the gene within the evolutionarily conserved motifs of the JAG1 protein. There is no phenotypic difference between patients with deletions of the entire JAG1 gene and those with intragenic mutations, which suggests that one mechanism involved in AGS is haploinsufficiency. The two missense mutations occur at the same amino acid residue. The mechanism by which these missense mutations lead to the disease is not yet understood; however, they suggest that mechanisms other than haploinsufficiency may result in the AGS phenotype.

Indexed as

MutationAlagille SyndromeAmino Acid SequenceAnimalsCalcium-Binding ProteinsCohort StudiesDNA Mutational AnalysisGene DeletionGenotypeHumansIntercellular Signaling Peptides and ProteinsJagged-1 ProteinMembrane ProteinsMolecular Sequence DataPhenotypeProteinsCalcium-Binding ProteinsIntercellular Signaling Peptides and ProteinsJAG1 protein, humanJagged-1 ProteinMembrane ProteinsProteinsSerrate-Jagged Proteins

Identifiers

PMID9585603
PMCPMC1377154
OpenAlexW2166911309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.